Pilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic Cancers

NCT04611139 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Salarius discontinued support

Conditions

SCCOHT
Ovarian Clear Cell Tumor
Ovarian Endometrioid Adenocarcinoma
Endometrial Cancer

Interventions

DRUG: SP-2577
DRUG: Pembrolizumab

Sponsor

HonorHealth Research Institute

Collaborators

[object Object]
[object Object]